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Quantification of muco‑obstructive 
lung disease variability in mice 
via laboratory X‑ray velocimetry
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To effectively diagnose, monitor and treat respiratory disease clinicians should be able to accurately 
assess the spatial distribution of airflow across the fine structure of lung. This capability would enable 
any decline or improvement in health to be located and measured, allowing improved treatment 
options to be designed. Current lung function assessment methods have many limitations, including 
the inability to accurately localise the origin of global changes within the lung. However, X‑ray 
velocimetry (XV) has recently been demonstrated to be a sophisticated and non‑invasive lung function 
measurement tool that is able to display the full dynamics of airflow throughout the lung over the 
natural breathing cycle. In this study we present two developments in XV analysis. Firstly, we show 
the ability of laboratory‑based XV to detect the patchy nature of cystic fibrosis (CF)‑like disease in 
β‑ENaC mice. Secondly, we present a technique for numerical quantification of CF‑like disease in mice 
that can delineate between two major modes of disease symptoms. We propose this analytical model 
as a simple, easy‑to‑interpret approach, and one capable of being readily applied to large quantities 
of data generated in XV imaging. Together these advances show the power of XV for assessing local 
airflow changes. We propose that XV should be considered as a novel lung function measurement 
tool for lung therapeutics development in small animal models, for CF and for other muco‑obstructive 
diseases.
Cystic fibrosis (CF) is a progressive, chronic and debilitating genetic disease caused by mutations in the CF 
Transmembrane-conductance Regulator (CFTR) gene. Unrelenting CF airway disease begins early in infancy 
and produces a steady deterioration in quality of life, ultimately leading to premature death. Effective lung health 
assessment tools must capture the patchy nature of muco-obstructive lung diseases such as cystic fibrosis, and 
this is particularly important during the early stages of the disease when local treatments could be applied to 
prevent disease progression.
Assessments of overall lung health in humans and animals are typically made using lung function tests that 
screen for abnormalities by measuring the flow of gas in the airways. Spirometry is the most common tool for 
assessing lung function, however it measures global airflow at the mouth. This means that parameters such as 
 FEV1 are a single, global measure of the health of the entire lung, are effort-dependent, and provide no infor-
mation about the location of muco-obstructive disease. Multiple breath wash-in or wash-out techniques that 
measure the lung-clearance index (LCI) are sensitive to some changes in CF disease as they reflect the health 
of both the small and large  airways1, 2, but can only provide limited regional airflow information. LCI is rarely 
reported in laboratory animal studies. The forced oscillation technique (FOT) measures the resistive properties 
of the respiratory system and has been used in obstructive lung disease assessment, although the results can be 
difficult to interpret. Furthermore it suffers from the same problems as  FEV1 with respect to lumping regional 
information into single whole-lung  parameters3. These kinds of techniques that are used clinically can also be 
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applied in animals using current gold-standard tools such as the flexiVent (Scireq, Canada), to measure some 
of the effects of pharmaceutical and genetic therapeutics in animal  models4. Regardless of the measurements 
that can be provided by these common measures of lung function, they cannot accurately localise the changes 
in airflow that are caused by structural abnormalities within the lung.
To identify structural lung disease, image-based assessments such as CT and MRI are commonly used in 
humans and animal models. CT provides excellent structural information, and can therefore be used to monitor 
for structural abnormalities from disease progression, or morphological changes produced by new drug thera-
pies. However, preventative treatment programs should ideally be able to intervene before disease establishes 
and progresses to the point at which it produces structural changes. Similarly, therapeutics assessments should 
be able to detect early functional  changes4. MRI has the advantage of being able to simultaneously observe 
both lung function and structure without exposing the subject to ionising radiation. However, progress in MRI 
research has lagged behind x-ray-based methods, most likely because spatial resolution is poor and the properties 
of the lung—particularly the low proton density, present since the lung is comprised primarily of air—make it 
less appropriate for  MRI5. Nonetheless, recent innovations such as hyperpolarised gas and ultrashort echo time 
imaging continue to advance human chest MRI  research6, 7.
Methods that attempt to infer lung function from CT and MRI images have previously been reported in 
humans and animals. Spirometry-guided CT for volume control during imaging has potential benefits but has 
not been implemented on a large scale and requires extensive patient training to  administer5. Scoring systems 
that use software analyses to validate outcome measures from chest CTs have been developed, including the 
PRAGMA-CF assessment protocol for monitoring early-stage CF in  children8. These methods must still look to 
repeatability and standardization of results, as well as restrictions associated with radiation dose from repeated 
chest  CTs9. Other developments that show promise include registration-based techniques for measuring lung 
 aeration10–12, and the use of contrast agents to render lung content directly  visible13, 14. Tracking X-ray microscopy 
(TrXM) takes advantage of a sophisticated synchrotron-based X-ray imaging system to directly image mouse 
alveoli during  respiration15.
Despite the availability of techniques that assess either lung function or lung structure, none of these are 
able to simultaneously identify the origin of changes in function, and evaluate their heterogeneity. Abnormal 
lung motion during breathing has been demonstrated to be an indicator of  disease16. Our previous research 
has developed a method that can rapidly capture the motion of the natural breathing cycle at a high spatial and 
temporal resolution, without the use of a contrast agent. To do this, propagation-based phase-contrast X-ray 
imaging (PCXI) was utilised. Since PCXI does not rely solely on absorption of X-rays by matter—but rather the 
diffraction of rays at material interfaces enhanced by the propagation of x-rays through free space—it can reduce 
the radiation dose and health risk associated with conventional chest CT  scans17–19. PCXI can be combined 
with tomography to create detailed three-dimensional reconstructions of the fine structures in the  lungs20–23. 
Using multiple PCXI images acquired throughout the respiratory cycle, Fouras et al.16 applied particle-image 
velocimetry to determine the speed and direction of lung motion in three dimensions throughout the respira-
tory cycle. The resulting regional maps of lung tissue motion can be used to detect subtle and non-uniform lung 
 disease24–26. This high-speed PCXI acquisition and post-processing analysis is termed X-ray velocimetry (XV). 
The key difference between standard structural imaging modalities and XV is that XV assesses the dynamics of 
the lung tissue movement throughout the breath in order to extract measures of tissue expansion. The result is 
a detailed ventilation map of the lung, which non-invasively enables the volume of air that flows through each 
branch of the lung tree to be  calculated21.
The potential value of XV for inferring lung function is shown by the characterisation of CF-like lung disease 
in small laboratory animals at high resolution using a synchrotron-based X-ray  source24, where the spatial and 
temporal variability in airflow throughout the lung was assessed. Recently, Murrie et al. reported the proof-
of-principle translation of XV to a laboratory-based  source25. They showed that despite a loss of spatial and 
temporal coherence—which is inevitable when moving from a high-brightness synchrotron to a compact light 
source—XV data can still be extracted from the resulting images. In the present study, the same laboratory-based 
X-ray source was used to perform XV on a cohort of β-ENaC mice, a model of CF-like lung  disease26. This data 
was then used to develop novel numerical methods that delineate symptoms of this disease. The success of XV 
lies in its ability to draw reliable and meaningful quantitative measures, and this study shows how this can be 
accomplished. In the future these techniques can be expected to be applied to the numerical characterization of 
CF lung disease in larger cohorts and other CF animal models. These methods allow analyses to be applied in a 
straightforward fashion and with minimal manual processing, to enable ongoing study and development of the 
treatment of CF and other respiratory diseases.
Results and analysis
Here methods for extracting quantitative measures for lung health from the XV data are presented. These can 
be readily applied to large datasets with minimal manual intervention.
Regional distribution of lung function. Figure 1 maps the regional expansion of the lungs at the peak 
of the breath for both a β-ENaC mouse and its healthy littermate, as measured by XV. The expansion of each 
region of interest (ROI), defined by the XV voxel, is given as a fractional increase over the course of the breath, 
i.e. (change in volume of ROI)/(volume of ROI). The resulting measurement, fractional expansion, is a unitless 
quantity.
The XV expansion data shown in Fig. 1 clearly allows the location of the airflow deficits to be determined 
within this plane inside the lung (see red arrow in panel 1a). In order to quantify differences throughout the 
entire lung volume, methods of calculating the distribution of tissue expansion have been developed here. An 
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example of this approach is shown in Fig. 2a, which shows a histogram calculated from the fractional tissue 
displacement across the volume of the lung for each mouse shown in Fig. 1. The measurements for the β-ENaC 
mouse (from Fig. 1a) are shown in red and its healthy littermate (from Fig. 1b) in blue. The interquartile ranges 
(IQR) of each histogram are indicated in the graph. To adjust for variations in lung size across the cohort, the 
area under each histogram has been normalised to 1. In a homogeneously ventilated lung, the range of values 
for fractional tissue displacement should be narrow. In circumstances where there is heterogeneity due to a 
‘patchy’ disease such as cystic fibrosis, a wider range of values (and therefore a higher IQR) is expected due to 
varied areas of poor ventilation and air trapping from mucus obstruction, as shown in Fig. 2a. Also apparent in 
the histogram from this particular β-ENaC mouse is the bimodal peak, where the lower peak represents regions 
of poor lung health (airflow), as indicated by the red arrow in Fig. 1a. This is likely to be caused by the presence 
of mucus obstruction which is a feature of this animal  model27, 28. Our previous synchrotron-based  study24 used 
Figure 1.  Regional fractional expansion of the lung since the beginning of the breath is characterized as a 
fraction of the XV voxel. Coronal slices of the expansion at peak inspiration are shown for (a) a β-ENaC mouse 
(M3) and (b) a healthy littermate (M9). The red arrow indicates a large region with reduced expansion in the 
lungs of the β-ENaC mouse. This image, and all images like it in this paper, are generated by superimposing 
3D fractional expansion data onto a 3D rendered volume of the lungs, before taking a coronal slice of the now 
pseudo-coloured volume (Avizo, ThermoFisher Scientific).
Figure 2.  Comparative lung expansion analysis for a β-ENaC (M3, red) and littermate (M9, blue) pair of mice. 
(a) A histogram analysis of the fractional tissue displacement for the littermate and β-ENaC mice from Fig. 1, 
with the interquartile ranges of the normalised histogram shown as IQR. Note that Fig. 1 shows a single coronal 
slice, whereas the histogram is calculated from the entire volume. The fractional expansion for the β-ENaC 
mouse has a split peak. (b) The volume/time curve over the course of the ~ 0.5 s breath for the entire lung 
provides a global measurement of lung health. The volume of air breathed throughout the breath is expressed as 
a fraction of the entire lung volume; fractional volume. The healthy mouse breathes more air relative to the size 
of its lung. From this we can calculate the global expiratory time constant (τ).
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histological sections to confirm that areas of reduced ventilation as measured by by XV analysis corresponded 
to mucus blockages in the bronchial  tree24.
Concurrently, the global (total) expansion of the lung at each point in the breath was calculated in order to 
demonstrate the superiority of XV in its ability to produce information about the spatial distribution of lung 
function at any point in the breath, rather than a single global measure of lung function averaged across the entire 
breath. The global expiratory time constant (τ) (defined previously  in24), is calculated as the time taken for 67% 
(∼ 1/
√
2 ) of the air to be expired from the lungs. The volume in Fig. 2b is calculated from the total magnitude 
of the 3D tissue displacement vectors over the entire lung for each point in time, and is normalised according to 
the total lung volume, which was calculated by evaluating the volume of the mask used for tissue segmentation 
(see “Image processing”). The purpose of this normalisation is to be able to express the volume of air breathed as 
a fraction of the total lung volume. In this example, the β-ENaC mouse has a fractional tidal volume that is lower 
than its healthy counterpart due to poorer expansion in some parts of the lung. Note that the measurements in 
Fig. 2b are expressions of the average health across the whole lung, without reference to the local distribution 
across the lung, and is analogous to measures such as  FEV1. In contrast, the fractional expansion histogram 
(Fig. 2a) contains many spatially-separated measurements for the lung at the peak of the breath and is designed 
to visualise the airflow heterogeneity in the presence of this muco-obstructive disease.
Quantifying distribution of disease. As with human CF lung disease, there can be substantial variability 
in the severity and location of muco-obstructive disease between individual β-ENaC mice. Various presenta-
tions of CF-like disease have been categorised using the expansion histograms generated from the XV tissue-
displacement calculations, by assigning numerical quantities to characterise their shape. In the implementation 
presented here a simple least-squares fit for a Gaussian distribution was adopted, and the statistical moments 
of the fitted curve have been used to numerically characterise the profile of the histogram and relate them to 
symptoms of disease. Figure 3 shows the histogram of nine different animals each with a score for two properties 
that describe how lung airflow is distributed throughout the lung. The measured local expansion across the lung, 
Figure 3.  (a–c) show histograms from healthy littermates and (d–i) are those from β-ENaC mice. On each 
graph; the grey lines form the point along the histogram of the fraction expansion data and the broken black 
line represents the least squares double-Gaussian fit for the data. The goodness-of-fit is shown as  R2. The extent 
of heterogeneous and clustered diseased is represented by HD and CD respectively, where a low CD and an HD 
value close to 1 indicates a healthy profile. In (h), the separate mode is indicated by the red arrow in addition to 
the bulge on the side of the main mode (blue arrow). The double gaussian fit summarises both deviations into a 
single curve.
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which represents functional changes, may collect around certain values (clustered) or vary widely (heterogene-
ous), thus each mouse is scored for the presence of either heterogeneous disease (HD) and clustered disease 
(CD), as defined below. All of the plots show the histogram of the raw data in a grey unbroken line, with the black 
broken line showing the nonlinear regression line-of-best-fit calculated by applying a least squares approxima-
tion to a double-Gaussian curve. The goodness-of-fit is shown on each figure as  R2. For this experiment, three 
categories of histogram profiles are seen:
Healthy The healthy animal shown in Fig. 2a (blue histogram) shows a typical tall and narrow expansion 
histogram from a healthy mouse lung, showing expansion data that falls into a narrow range and which 
represents homogeneous expansion. Figure 3a–c show the expansion histograms from three healthy mice, 
showing the characteristic tall and narrow peak.
Heterogeneous disease (HD) When CF-like disease is established across the lung, we expect XV to demonstrate 
characteristic heterogeneous lung function, with the disease presenting across the volume of the lung. In lieu 
of a tall and narrow peak where most of the lung expands evenly (by the same percentage), we expect a low 
and wide peak, with a larger range of values as some parts of the lung expand less than other parts. Each 
sample receives a score for patchiness, calculated using the term IQR/IQRL
_
 where IQR is the interquartile 
range of the histogram and IQRL
_
 is the average interquartile range for the littermate population. A healthy 
lung will have a value of close to 1 (see Fig. 3a–c), with the score increasing as lung health becomes more 
heterogeneous. Figure 3d–f show profiles for heterogeneous disease, each with a low and wide peak and higher 
HD values. Figure 3f has a heterogeneity level of 1.78, or rather 178% of healthy lung function variation.
Clustered disease (CD) If airways are partially obstructed with mucus, poor ventilation and air trapping in the 
regions of the lung that receive air via those obstructed airways may result. In the end stages of this disease 
this may result in permanent damage to those regions due to atelectasis or bacterial infections that have been 
brought on by the presence of mucus. Where there is mucus preventing ventilation to a region of the lung, 
this region is less healthy than the rest of the lung, resulting in a clustered disease presentation. In the histo-
gram of the expansion data, this is typically expressed as bimodality, or a split peak (as there could be two or 
more distinct regions). The diseased mouse in Fig. 2a shows such a peak. In order to determine whether or 
not the histogram of some expansion data possessed a second peak and how distinct the split between the 
peaks was, in this implementation a double-Gaussian distribution was consistently fit to each histogram. It 
was then possible to provide a score for bimodality using the term (μ2–μ1)/μ2; where μ1 and μ2 are the values 
of the two modes, or rather the mean values of each peak in the double Gaussian distribution. Note that a 
double-Gaussian function was fitted to the data not because we assumed the data followed a normal distri-
bution, but because the characteristics of a Gaussian distribution (smooth, tends to zero at ±∞ ) made it a 
suitable basis function, conveniently applied to our data to readily extract functional measures. Low levels of 
mucus plugging of the large airways are indicated by low CD quantities in Fig. 3a–c. Figure 3f shows levels 
of clustered disease approaching 0.34, where a second peak is beginning to separate itself from the central 
mode. Figure 3g–i show expansion histograms with distinct CD presentation. In Fig. 3h, the algorithm has 
failed to pick up on the peak that is indicated by the red arrow. This is likely because there are three different 
regions, not two. The middle region (blue arrow) is not well-separated from the central mode. While the 
label ‘clustered’ strictly refers to a grouping of expansion values within the histogram, it is typical that this is 
associated with a spatial grouping of low-expansion pixels within the lung image.
Figure 4 shows coronal slices through the 3D expansion volumes that correspond to the histograms in Fig. 3.
In Fig. 5 the HD and CD values at the peak of the breath are plotted against the tissue hysteresivity (measured 
by FOT). In Fig. 5a, XV measurements that suffer from excessive “heart blur” (shown in black—this imaging 
artefact is described in the section below) are separated from the rest of the data points, which are themselves 
divided into β-ENaC (red) mice and their healthy littermates (blue). The blue data points consistently present 
with an HD index ~ 1, a homogeneous lung function presentation, while the red data points show greater varia-
tion, which is consistent with the range of disease presentation as exemplified earlier in the “Results and analysis” 
section. It is not expected that the full complexity of respiratory disease can be captured with a single measure-
ment; nonetheless this simple plot shows a correlation with FOT measurements. Figure 5b further shows the 
large range of disease presentations that are seen within the group of β-ENaC mice, in this case characterised 
using the cluster disease index (CD). More variation is expected amongst samples with CF-like disease, due, for 
example, to the variability in symptoms discussed in “Results: quantifying symptoms of disease”.
Heart blur. As described in “Methods” the image acquisition was coordinated with ventilation. The heart, 
however, beats independently of image acquisition, resulting in some lung motion blur. Due to the spatial and 
temporal resolution of the laboratory-based source, along with the small exposure times required to acquire 
XV images, this blurring could cause local failure of the XV algorithm when it attempts to faithfully capture 
speckle motion. Figure 6 shows examples from four separate animals. Dubsky et al.29 used XV technology to 
show the manner in which cardiogenic oscillations affect airflow around the lung, by calculating the resulting 
tissue displacement. Their work showed that significant lung movement due to cardiac excursions is seen in the 
lower left regions of the lungs. This was also seen in our data, with the lower left region of the lungs (red arrows, 
Fig. 6) blurred in the CT image, preventing accurate measurement of tissue displacement using XV analysis. This 
resulted in unrealistic HD and CD values.
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A single CT slice from the first time point of the breath for mouse M11 above reveals this heart-motion 
associated blurriness (Fig. 7, red arrows). For comparison, the yellow arrows show a well-defined lung edge, 
situated away from the heart region.
The methods for detecting heart blur issues numerically are presented below in the “Discussion”.
Figure 4.  Coronal slices through the 3D expansion volumes that correspond to the histograms shown in Fig. 3, 
with the same mice shown in corresponding panels. Panels (a–c) show expansion maps from healthy littermates 
and (d–i) are those from β-ENaC mice. Note that a slice can reveal only a fraction of the whole volume, so does 
not necessarily reflect the level of disease heterogeneity that is apparent in Fig. 3.
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Figure 5.  Plot of HD and CD against FOT results for tissue hysteresivity. We expect larger values for all 
quantities in animals with more severe disease, but we have shown the CF-like disease presents in a more 
complex manner than can be captured by a single quantity; while littermates are clustered closely together, 
β-ENaC points clearly display large variability in the lung disease present in these mice. (a) We have separated 
the images/samples we assessed to be suffering from heart blur (black) from the rest of the samples; (b) CD is 
not calculated for heart-blur samples.
Figure 6.  Heart blur throughout four different samples—all littermates—indicated by the red arrows. These 
areas record zero tissue displacement, as indicated by the colorbar at the left of the images.
Figure 7.  A single CT slice from the first frame of sample M11. The arrows indicate the distinction between 
a blurred edge (red) between the heart and lung, as a result of heart motion, and a well-defined edge (yellow), 
more distant from the heart.
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Discussion
This study successfully shows that XV—when performed on a laboratory  source25—can capture and differentiate 
a range of lung disease presentations seen in β-ENaC mice via the novel quantification methods described here. 
Currently, clinically feasible methods for the quantification of regional lung airflows and heterogeneity are sparse, 
but this study shows that it is possible to measure the dynamics of muco-obstructive disease presentations in 
large groups of animals using XV without the need for a synchrotron X-ray source.
A significant outcome of this work is to provide the proof-of-principle for a straightforward means of numeri-
cally evaluating small animal lung health in the presence of symptoms of CF-like disease. It has been shown that 
the histogram for regional tissue displacement enabled by XV analysis provides information about the variability 
of airflow within the lung. Using the model described here, consisting of a score for both clustered disease (CD) 
and patchy/heterogeneous disease (HD), an overall presentation of CF-like disease can be quantified numeri-
cally. Combinations of these symptoms can account for a more rigorous approach to lung function evaluation 
than other techniques (e.g. a traditional lung function breath measurement such as spirometry, which measures 
breathing at the mouth and so averages airflow effects over the whole lung). When compared to FOT measure-
ments for tissue hysteresivity, the HD score shows similarly low values for healthy animals. For diseased animals, 
there is greater variation—a complexity of presentation that can not be captured by a single measurement.
In future studies this scoring system should be suited to analysis of the accuracy of this system in separating 
disease states in larger cohorts, by using Machine Learning analysis of clustering and association of data points 
(as  with30). Since the HD score is normalised to the mean variance of the healthy population, a new group of 
animals would have different baseline characteristics. Larger sample sizes would also enable us to use a Deep 
Learning model  (see31) to determine the thresholds for the HD and CD which correspond to muoco-obstructive 
disease at its various stages. Future investigations can also determine the optimal combination of Gaussian curves 
which provides the best measure of CD. The use of more powerful statistical techniques such as functional data 
analysis for describing the shape of the  histogram32 should also be investigated, along with an examination of 
how other respiratory conditions present using these numerical XV characterisations.
The challenge of processing the volume of data that is required to develop this model presented here will be 
made easier with the inclusion of algorithms that can independently search data to detect symptoms of disease, 
without the need for user input. A number of image analysis algorithms are in development in order to accom-
plish this. For example, to orient each sample identically, we have implemented a mirrored symmetry approach 
on a CT image dataset that has been projected in the cranial/caudal direction to find the position of the spine, 
as shown in Fig. 8. The symmetry of the image is evaluated by comparing the features of the image with those 
of its  reflection33, 34. Ultimately, the image is rotated to a position whereby the spine lies at the bottom of the 
image, to facilitate automated cropping. Correcting orientation provides the means to associate data points 
with their physical location across the lung, allowing, for example, automatic identification of heart blur due to 
characteristic proximity to the  heart29.
Manual segmentation of the conducting airways or lung lobes, a preliminary step to XV, is time-consuming. 
Although providing impressive visualisation of lung function and highly accurate localisation of obstruction 
results, the inclusion of a manual step is not practical for large datasets. As a result, elements in image process-
ing have been established that are designed to automatically segment the lungs from surrounding tissue, using 
thresholding, 3D morphological filters and continuity checks between slices. This approach will allow for the 
analysis of XV datasets to move from a new technique requiring some analysis training and effort into a highly 
accessible technique that can routinely evaluate large sets of data.
To address the challenge of heart blur, Lovric et al.35 have implemented a heartbeat-triggering gating tech-
nique into their image acquisition, although this is likely to be particularly challenging at the very high frame 
rates required for acquiring XV images at high ventilation rates. While experimental parameters have been 
optimised with the set-up for this  experiment36, using a smaller spot size and higher power for the X-ray source, 
or a more sensitive detector, can increase the phase signal and reduce the amount of noise and blurriness in the 
X-ray images to improve our capabilities.
Figure 8.  Mirror symmetry algorithm for automatic orientation and cropping. (a) A single slice from a CT 
reconstruction, pre-cropping. In (b), slices of the CT have been projected in the cranial/caudal direction to 
create a single image and the image thresholded to show the bones, revealing the symmetry of the ribcage. The 
red line indicates the line-of-best-symmetry as found by the algorithm, passing through the spine and sternum, 
allowing us to register their positions. (c) Using this result, the algorithm automatically corrects the orientation 
of the sample, and crops the image to the bones that act as a boundary for lung tissue; (d) shows a rotated and 
cropped slice. 
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Translating XV to a laboratory-based X-ray source creates challenges associated with lower spatial resolution 
than what is available with a synchrotron-based source. However, the use of magnification at the laboratory X-ray 
source enables the use of large, highly-efficient pixels that can reduce the associated radiation dose, which is a key 
step on the translational path to the clinic. Rather than imaging the fine structures of the lungs at the very high 
resolution (and hence high dose) required to directly observe the presence of disease, disease can be inferred 
by analysing the expansion maps produced by XV. The subject can consequently be exposed to lower amounts 
of ionising radiation than would be required if these blockages were to be resolved directly. Techniques such as 
FOT and  FEV1 provide single measures of lung function that are difficult to interpret alone, such that lung CT is 
often required to identify the structural abnormalities that might be the source of the change in lung function. 
The XV analysis technique presented here provides a more regional analysis of function across the lung and 
throughout the breath and provides the researcher, uniquely, the locations of airflow dysfunction Thus, XV has 
the potential to become a routine diagnostic tool to measure and monitor animal models, and ultimately humans, 
for improvements or declines in lung health. To translate XV to human use we have tomosynthesis experiments, 
large animal studies, and human clinical trials underway. Finally, XV will have applications beyond CF lung 
disease, and have value in other respiratory diseases such as asthma, COPD, emphysema and lung cancer, and 
in the development and assessment of respiratory therapeutics.
Conclusions
Here, laboratory-based XV has been applied to the evaluation of lung disease heterogeneity in a group of β-ENaC 
mice and their healthy littermates. We also present a novel, straightforward and intuitive method for quantifying 
the distribution of their muco-obstructive disease. Future automated approaches will allow the application of 
this model to large sets of data in order to observe lung function changes during treatment, to develop a robust 
numerical model for CF lung disease. The combination of X-ray velocimetry and progressive automation of the 
data analysis is an important step in the development of more sophisticated methods of lung function testing, 
and should assist research internationally to improve the health and lives of people with cystic fibrosis, and a 
range of other lung diseases.
Methods
Image acquisition. All images were acquired at the Laboratory for Dynamic Imaging at Monash University 
on a propagation-based PCXI set-up shown in Fig. 9, with the X-ray beam (Excillum D2+, Excillum AB, Kista, 
Sweden) produced by an electron beam striking a liquid–metal anode. A high power (265 W) was used over a 
small source (spot size: 60 μm × 15 μm) to generate the flux needed to achieve an imaging rate of 30 frames per 
second, and coherence sufficient to generate the phase contrast necessary across the lung  volume37. With a con-
Figure 9.  A diagram of the image acquisition process. (a) Experimental schematic: The mouse is mounted on 
a rotation stage in front of the x-ray beam, generated by an electron beam hitting the liquid–metal jet anode, 
pumped under high pressure to retain a laminar flow. A small-animal ventilator ensures that the detector 
acquires images at a rate that is synchronized to the breathing pattern of the mouse. The vacuum tube (not 
shown) lies between the mouse and the detector; (b) An example of a single projection image collected by the 
detector as the animal is rotated in front of it; (c) A single slice from the CT reconstruction of the projections 
from a single time point (Adapted  from25).
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ventional solid-metal anode, one would have to take care not to overheat the target while attempting to generate 
a higher flux. However, by using a liquid–metal-jet anode—pumped under high pressure to maintain a laminar 
flow—there was no concern of approaching the limits of heating the metal target in order to extract sufficiently 
high flux.
The source-to-detector distance was fixed at 3,363 mm, with a maximum source-to-sample distance of 
467 mm. The translation stage enabled the mice to be moved toward and away from the source to alter the 
zoom factor as required. To produce phase contrast in the resulting images, a minimum propagation (sample to 
detector) distance of 2,896 mm (through the ~ 30 cm diameter vacuum tube) was used. To minimise scattering 
and avoid an associated reduction in image contrast, the x-rays were propagated through a vacuum tube before 
reaching the detector.
Animal experiments. All experiments were approved by the Monash University Animal Ethics Commit-
tee and conformed to the guidelines set out in the NHMRC Australian Code of Practice for the Care and Use of 
Animals for Scientific Purposes.
β-ENaC mice (n = 15), aged 45–84 days (median = 62 days) at the time of imaging, were used for all 
 experiments26. Mice were bred on a C57Bl/6N background, and supplied from our specific pathogen-free breed-
ing colony (Monash Animal Research Platform). Littermate controls (n = 10) were used to minimise the effects 
of strain on the lung phenotype. Offspring were genotyped at 3 weeks of age via PCR of genomic DNA as previ-
ously  described26.
Mice were anaesthetised with an intraperitoneal (i.p) injection of a 10 μl/g body weight mixture of medeto-
midine (0.1 mg/ml, Orion Corporation, Finland) and ketamine (7.6 mg/ml, Parnell Laboratories, Australia), 
and surgically intubated. The endotracheal tube was attached to a custom-built small animal pressure-controlled 
ventilator (AcuVent, Notting Hill Devices, Australia) at 12  cmH2O PIP and 2  cmH2O PEEP with a respiratory rate 
of 120 breaths per minute (inspiration time of 0.15 s and an expiration time of 0.35 s). To maintain the normal 
dynamics of lung function, a paralytic was not used.
Mice were mounted in a vertical position in front of the source on a custom high-precision rotation stage 
(Zaber Technologies, Vancouver, Canada). Mice were rotated through 360 degrees at 1.5 degrees per second 
while a flat-panel detector (PaxScan, Varian Medical Systems, Palo Alto, CA, USA) captured images at the rate 
of 30 Hz to acquire a total of 7,200 images per mouse. Image acquisition was triggered by the ventilator, and was 
gated to collect 15 images throughout the breathing cycle. Airway pressure and flow were monitored throughout 
the experiments.
At the completion of the imaging experiments, global lung mechanics were measured using a modification of 
the forced oscillation technique (FOT). Mice were hyperventilated at 400 breaths per minute for 60 s to induce 
brief (6 s) periods of apnea. During apnea, an oscillatory signal, generated by a loudspeaker, containing 9 frequen-
cies ranging from 4–38 Hz was introduced into the tracheal cannula via a wavetube of known impedance. The 
impedance of the respiratory system (Zrs) was calculated. A four-parameter model with constant phase tissue 
 impedance38 was fit to the data to Zrs spectrum allowing determination of tissue hysteresivity which is calculated 
as the ratio of the tissue damping to tissue  elastance39.
Image processing. To complete the XV cross-correlation analysis, the 7,200 projections were organised, or 
binned, into their time points resulting in 400 projections per time point, with a total of 15 time points across 
the 500 ms breathing period. Computed tomographic reconstruction was performed for each set of projections 
giving 15 separate CT reconstructions, one for each of the 15 stages of the breath. Each CT consisted of 1,024 
slices, each 1,024 pixels by 1,024 pixels. The effective voxel size varied from mouse-to-mouse.
Using Avizo software (ThermoFisher Scientific), the CT volume representing the beginning of the breath was 
used to create a mask for isolating the lung tissue from the rest of the animal. The volume of the mask was also 
used to determine the total voxel size of the lung, which, after accounting for variation in effective voxel size, 
was used to normalise the volumetric results.
For XV, an interrogation region size of 64 ⨉ 64 ⨉ 64 pixels with an overlap of 50% between successive inter-
rogation windows were used, producing a XV voxel size of 32 ⨉ 32 ⨉ 32 pixels. The XV output showed the 
magnitude and direction of the lung tissue motion vectors between each time point. This displacement of tissue 
denotes lung expansion, and was expressed in voxels per frame. The mainstem bronchi were removed from the 
expansion map images to improve clarity.
Data availability
The data that support the findings of this study are available on reasonable request from the corresponding 
authors. The XV analysis code that supports the findings in this study is not publicly available due to patent 
restrictions. Code may however be available from the authors upon reasonable request and with permission of 
Monash University and 4Dx Limited.
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